Advertisement

Pharmaceutic Prodigy of Ergosterol and Protein Profile of Ganoderma lucidum

  • Anna Goyal
  • Anu Kalia
Chapter
Part of the Fungal Biology book series (FUNGBIO)

Abstract

Ganoderma lucidum, a specie belonging to the class basidiomycetes, family polyporaceae of the order aphyllophorales has been widely utilized as a source of potential nutracuetical products. The cell wall of Ganoderma lucidum contains ergosterol which gets increased over different stage of the cultivation process. Ergosterol serves as the precursor for vitamin D, serves as the immunodulating agent in cancer suppression and has been the molecule of choice for antimycotic drug development. Thus, drug formulations of ergosterols or its conjugating complexes may enhance immunity and Vitamin D levels in the body. Ganoderma lucidum is also a rich source of pharmaceutical proteins and protein bound polysaccharides that can also serve as anti-cancer agents thereby improving the immune status of the individual. Other proteins found in Ganoderma lucidum are the morphogenesis related proteins such as hydophobins and an elaborate antioxidant enzyme machinery synthesized during the developmental stages. The intracellular and extracellular enzymatic profile of Ganderma exhibits enhanced activity during spawn run and pinning of the cultures. A positive role of hydrophobic amino acids and hydrophobin proteins has been identified in mushroom fructification process. Thus, medicinal mushroom such as Ganoderma can serve as a potential reservoir of bioactive compounds of pharmaceutic importance that can be utilized for prevention and cure of several disorders.

Keywords

Antioxidant enzymes Ergosterol Hydrophobins Immune-modulating Protein 

References

  1. Alcazar-Fuoli L, Mellado E, Garcia-Effron G, Lopez JF, Grimalt JO, Cuenca-Estrella JM (2008) Ergosterol biosynthesis pathway in Aspergillus fumigatus. Steroids 73(3):339–347PubMedCrossRefGoogle Scholar
  2. Arthington-Skaggs BA, Warnock DW, Morrison CJ (2000) Quantitation of Candida albicans ergosterol content improves the correlation between in vitro antifungal susceptibility test results and in vivo outcome after fluconazole treatment in a murine model of invasive candidiasis. Antimicrob Agents Chemother 44(8):2081–2085PubMedPubMedCentralCrossRefGoogle Scholar
  3. Aswad AWM, Sariaha M, Paterson RRM, Abidinb MAZ, Limac N (2011) Ergosterol analyses of oil palm seedlings and plants infected with Ganoderma. Crop Prot 30:1438–1442CrossRefGoogle Scholar
  4. Axelsson BO, Saraf A, Larsson L (1995) Determination of ergosterol in organic dust by gas chromatography-mass spectrometry. J Chromatogr B 666:77–84CrossRefGoogle Scholar
  5. Bach TJ, Benveniste P (1997) Cloning of cDNAs or genes encoding enzymes of sterol biosynthesis from plants and other eukaryotes: heterologous expression and complementation analysis of mutations for functional characterization. Prog Lipid Res 36:197–226PubMedCrossRefGoogle Scholar
  6. Bermingham S, Maltby SL, Cooke RC (1995) A critical assessment of the validity of ergosterol as an indicator of fungal biomass. Mycol Res 99:479–484CrossRefGoogle Scholar
  7. Berne S, Pohleven J, Vidic I, Rebolj K, Pohleven F, Turk T, Macek P, Sonnenberg ASM, Sepcic K (2007) Ostreolysin enhances fruiting in the oyster mushroom (Pleurotus ostreatus). Mycol Res 111:1431–1436PubMedCrossRefGoogle Scholar
  8. Bryant JM, Bouchard M, Haque A (2017) Anticancer activity of Ganoderic acid DM: current status and future perspective. J Clin Cell Immunol 8:535PubMedPubMedCentralCrossRefGoogle Scholar
  9. Chang ST, Buswell JA (2008) Safety, quality control and regulational aspects relating to mushroom nutriceuticals. Proc. 6th Intl. Conf. Mushroom Biology and Mushroom Products GAMU Gmbh, Krefeld. pp: 188–195Google Scholar
  10. Chang ST, Miles PG (2004) Mushrooms: cultivation, nutritional value medicinal effect and environmental impact, second edn. CRC Press, Boca RatonCrossRefGoogle Scholar
  11. Chao EE, Gruen HE (1987) Intracellular activity of mycelial proteinases during fruit-body development in Flammulina velutipes. Can J Bot 65:518–525CrossRefGoogle Scholar
  12. Chen AW (1999) Cultivation of the medicinal mushroom Ganoderma lucidum (Curt.: Fr.) P. karst. (Reishi) in North America. Int J Med Mush 1:263–282CrossRefGoogle Scholar
  13. Christie WW, Han X (2010) Lipid analysis - isolation, separation, identification and lipidomic analysis. Oily Press, BridgwaterGoogle Scholar
  14. Czub J, Baginski MJ (2006) Comparative molecular dynamics study of lipid membranes containing cholesterol and ergosterol. Biophys J 90:2368–2382PubMedPubMedCentralCrossRefGoogle Scholar
  15. Ellis D (2002) Amphotericin B: spectrum and resistance. J Antimicrob Chemother 49(1):7–10PubMedCrossRefGoogle Scholar
  16. Erkel EI (2009) The effect of different substrate mediums on yield of Ganoderma lucidum (Fr.) karst. J Food Agri Environ 7:841–844Google Scholar
  17. Figlas D, Curvetto N (2010) Medicinal mushroom reishi (Ganoderma lucidum). Main toxicity and allergenicity studies, dosage, posology and side effects. pp 1–13 http://hongoscomestiblesymedicinales.com/P/3%20G.pdf
  18. Gao YH, Sai XH, Chen GL, Ye JX, Zhou SF (2003) A randomized, placebo-controlled, multi-center study of Ganoderma lucidum (W. Curt.: Fr.) Lloyd (Aphyllophoromycetideae) polysaccharides (Ganopoly) in patients with advanced lung cancer. Int J Med Mushrooms 5:368–381Google Scholar
  19. Gessner MO, Schmitt AL (1996) Use of solid-phase extraction to determine ergosterol concentrations in plant tissue colonized by fungi. Appl Env Microbiol 62(2):415–419Google Scholar
  20. Gonzalez MN, Arndt M, Zomorrodi M, Majcherczyk A, Kües U (2011) Regulation of fruiting body formation in Coprinopsis cinerea. Proceedings of the 7th international conference on mushroom biology and mushroom products (ICMBMP7)Google Scholar
  21. Goyal A, Kalia A, Sodhi HS (2015) Selenium stress in Ganoderma lucidum: A scanning electron microscopy appraisal. Afr J Microbiol Res 9(12):855–862Google Scholar
  22. Goyal A, Kalia A, Sodhi HS (2016) High-performance liquid chromatography studies to estimate ergosterol content at different developmental stages of the lingzhi or reishi medicinal mushroom, Ganoderma lucidum (Agaricomycetes). Int J Med Mushrooms 18(12):1115–1120PubMedCrossRefGoogle Scholar
  23. Grille S, Zaslawski A, Thiele S, Plat J, Warnecke D (2010) The functions of steryl glycosides come to those who wait: recent advances in plants, fungi, bacteria and animals. Prog Lipid Res 49:262–288PubMedCrossRefGoogle Scholar
  24. Hawksworth DL (2001) Mushrooms: the extent of the unexplored potential. Int J Med Mush 3:333–337CrossRefGoogle Scholar
  25. Japelt RB, Jette Jakobsen J (2013) Vitamin D in plants: a review of occurrence, analysis, and biosynthesis. Front Plant Sci 4:136PubMedPubMedCentralCrossRefGoogle Scholar
  26. Kamada T (2002) Molecular genetics of sexual development in the mushroom Coprinus cinereus. Bioessay 24:449–459CrossRefGoogle Scholar
  27. Lacourt I, Duplessis S, Abba S, Bonfante P, Martin F (2002) Isolation and characterization of differentially expressed genes in the mycelium and fruit body of Tuber borchii. Appl Environ Microbiol 68:4574–4582PubMedPubMedCentralCrossRefGoogle Scholar
  28. Lau APS, Lee AKY, Chan CK, Fang M (2006) Ergosterol as a biomarker for the quantification of the fungal biomass in atmospheric aerosols. Atmos Environ 40:249–259CrossRefGoogle Scholar
  29. Lee IK, Yun BS (2007) Highly oxygenated and unsaturated metabolites providing a diversity of hispidin class antioxidants in the medicinal mushrooms Inonotus and Phellinus. Bioorg Med Chem 15:3309–3314PubMedCrossRefGoogle Scholar
  30. Lee JM, Kwon H, Jeong H, Lee JW, Lee SY, Baek SJ, Surh YJ (2001) Inhibition of lipid peroxidation and oxidative DNA damage by Ganoderma lucidum. Phytother Res 15:245–249PubMedCrossRefGoogle Scholar
  31. Lee SH, Kim BG, Kim KJ, Lee JS, Yun DW, Hahn JH, Kim GH, Lee KH, Suh DS, Kwon ST, Lee CS, Yoo YB (2002) Comparative analysis of sequences expressed during the liquid-cultured mycelia and fruit body stages of Pleurotus ostreatus. Fungal Genet Biol 35:115–134PubMedCrossRefGoogle Scholar
  32. Lees N, Skaggs B, Kirsch D, Bard M (1995) Cloning of the late genes in the ergosterol biosynthetic pathway of Saccharomyces cerevisiae – a review. Lipids 30:221–226PubMedCrossRefGoogle Scholar
  33. Leung GS, Zhang M, Xie WJ, Kwan HS (2000) Identification by RNA fingerprinting of genes differentially expressed during the development of the basidiomycete Lentinula edodes. Mol Gen Genet 262:977–990PubMedCrossRefGoogle Scholar
  34. Lin CH, Sheu GT, Lin YW, Yeh CS, Huang YH, Lai YC, Chang JG, Ko JL (2010) A new immunomodulatory protein from Ganoderma microsporum inhibits epidermal growth factor mediated migration and invasion in A549 lung cancer cells. Process Biochem 45(9):1537–1542CrossRefGoogle Scholar
  35. Lin SB, Li CH, Lee SS, Kan LS (2003) Triterpene enriched extracts from Ganoderma lucidum inhibit growth of hepatoma cells via suppressing protein kinase C, activating mitogen-activated protein kinases and G2-phase cell cycle arrest. Life Sci 72:2381–2390PubMedCrossRefGoogle Scholar
  36. Lochman J, Mikes V (2006) Ergosterol treatment leads to the expression of a specific set of defence-related genes in tobacco. Plant Mol Biol 62(2):43–51PubMedCrossRefGoogle Scholar
  37. Lugones LG, Wosten HAB, Wessels JGH (1998) A hydrophobin (ABH3) specifically secreted by vegetatively growing hyphae of Agaricus bisporus (common white button mushroom). Microbiol 144:2345–2353CrossRefGoogle Scholar
  38. Mai Huong L, Do HD, Thi HHT, Dung LV, Nguyen HN, Thi HNT, Nguyen LD, Hoang CK, Le HC, Thi THL, Trinh HT, Ha PT (2016) The dual effect of curcumin nanoparticles encapsulated by 1-3/1-6 β-glucan from medicinal mushrooms Hericium erinaceus and Ganoderma lucidum. Adv Nat Sci Nanosci Nanotechnol 7:045019CrossRefGoogle Scholar
  39. Mayzumi F, Okamoto H, Mizuno T (1997) Cultivation of Reishi (Ganoderma lucidum). Food Rev Int 13:365–382CrossRefGoogle Scholar
  40. Mizuno T (1997) Studies on bioactive substances and medicinal effect of Reishi Ganoderma lucidum in Japan. In: A committee (ed) Proc 1stInt Symp Ganoderma lucidum in Japan. Toyo-Igaku-Sha Co Ltd, Tokyo, pp 121–127Google Scholar
  41. Mizuno T, Wang G, Zhang J, Kawagishi H, Nishitoba T, Li J (1995) Ganoderma lucidum and Ganoderma tsugae: bioactive substances and medicinal effects. Food Rev Int 11:151–166CrossRefGoogle Scholar
  42. Ng WL, Ng TP, Kwan HS (2000) Cloning and characterization of two hydrophobin genes differentially expressed during fruit body development in Lentinula edodes. FEMS Microbiol Lett 185:139–145PubMedCrossRefGoogle Scholar
  43. Ooi VE, Liu F (2002) Immunomodulation and anti-cancer activity of polysaccharide-protein complexes. Curr Med Chem 7:715–729CrossRefGoogle Scholar
  44. Parkinson D, Coleman DC (1991) Methods for assessing microbial populations, activity and biomass. Microbial communities, activity and biomass. Agric Ecosyst Environ 34:3–33CrossRefGoogle Scholar
  45. Pasanen AL, Yli-Pietila K, Pasanen P, Kalliokoski P, Tarhanen J (1999) Ergosterol content in various fungal species and biocontaminated building materials. Appl Environ Microb 65:138–142Google Scholar
  46. Paterson RRM (2006) Ganoderma – a therapeutic fungal biofactory. Phytochemistry 67:1985–2000PubMedCrossRefGoogle Scholar
  47. Peksen A, Yakupoglu G (2009) Tea waste as a supplement for the cultivation of Ganoderma lucidum. World J Microbiol Technol 5:611–618CrossRefGoogle Scholar
  48. Pelkmans JF, Lugones LGZ, HAB W (2016) 15 fruiting body formation in Basidiomycetes. In: Wendland J (ed) Growth, differentiation and sexuality. The Mycota (A Comprehensive Treatise on Fungi as Experimental Systems for Basic and Applied Research). Springer, Cham, pp 387–405Google Scholar
  49. Penas MM, Ásgeirsdóttir SA, Lasa I, Macià FAC, Pisabarro AG, Wessels JGH, Ramírez L (1998) Identification, characterization, and in situ detection of a fruit-body-specific hydrophobin of Pleurotus ostreatus. App Environmen Microbiol 64:4028–4034Google Scholar
  50. Przybylowicz P, Donoghue J (1990) Shiitake growers handbook, the art and science of mushroom cultivation. Kendall/Hunt Publishing Co, USA, pp 151–155Google Scholar
  51. Rai RD (2003) Successful cultivation of the medicinal mushroom Reishi, Ganoderma lucidum in India. Mush Res 12:87–91Google Scholar
  52. Rayman MP (2005) Selenium in cancer prevention: a review of the evidence and mechanism of action. Proc Nutr Soc 64:527–542PubMedCrossRefGoogle Scholar
  53. Roberts CW, McLeod R, Rice DW, Ginger M, Chance ML, Goad LJ (2003) Fatty acid and sterol metabolism: potential antimicrobial targets in apicomplexan and trypanosomatid parasitic protozoa. Mol Biochem Parasitol 126(2):129–142PubMedCrossRefGoogle Scholar
  54. Rosecke J, Konig WA (2000) Constituents of various wood-rotting basidiomycetes. Phytochemistry 54:603–610PubMedCrossRefGoogle Scholar
  55. Rossard S, Roblin G, Atanassova R (2011) Ergosterol triggers characteristic elicitation steps in Beta vulgaris leaf tissues. J Exp Bot 61(6:1807–1816Google Scholar
  56. Sakamoto Y (2010) Protein expression during Flammulina velutipes fruiting body formation. Mycosci 51:163–169CrossRefGoogle Scholar
  57. Seitz LM, Mohr HE, Burroughs R, Sauer DB (1977) Ergosterol as an indicator of fungal invasion in grains. Cereal Chem 54:1207–1217Google Scholar
  58. Shao S, Hernandez M, Kramer JKG, Rinker DL, Tsao R (2010) Ergosterol profiles, fatty acid composition, and antioxidant activities of button mushrooms as affected by tissue part and developmental stage. J Agric Food Chem 58:11616–11625PubMedCrossRefGoogle Scholar
  59. Shieh YH, Liu CF, Huang YK, Yang JY, Wu IL, Lin CH, Lin SC (2001) Evaluation of the hepatic and renal protective effects of Ganoderma lucidum in mice. Am J Chin Med 29:501–507PubMedCrossRefGoogle Scholar
  60. Sio DF, Laratta B, Giovane A, Quagliuolo L, Castaldo D, Servillo L (2000) Analysis of free and esterified ergosterol in tomato products. J Agric Food Chem 48:780–784PubMedCrossRefGoogle Scholar
  61. Stamets P, Yao D (2002) Myco Medicinals: an informational treatise on the medicinal properties of mushrooms. Olympia, Wash.: Mycomedia productions, Fungi PerfectiGoogle Scholar
  62. Subbiah MTR, Abplanalp W (2003) Ergosterol (major sterol of baker’s and brewer’s yeast extracts) inhibits the growth of human breast cancer cells in vitro and the potential role of its oxidation products. Int J Vitam Nutr Res 73:19–23PubMedCrossRefGoogle Scholar
  63. Valachovic MC, Randall SK, Nickels JT, Bard M (2002) Protein-protein interactions among C-4 demethylation enzymes involved in yeast sterol biosynthesis. Proc Natl Acad Sci U S A 99(15):9739–9744PubMedPubMedCentralCrossRefGoogle Scholar
  64. Varga M, Bartok T, Mesterhazy A (2006) Determination of ergosterol in fusarium-infected wheat by liquid chromatography atmospheric pressure photoionization mass spectrometry. J Chromatogr 1103:278–283CrossRefGoogle Scholar
  65. Vikineswary S, Abdullah N, Renuvathani M, Sekaran M, Pandey A, Jones EBG (2006) Productivity of laccase in solid substrate fermentation of selected agro-residues by Pycnoporus sanguineus. Bioresour Technol 97:171–177PubMedCrossRefGoogle Scholar
  66. Wangspa R, Takemoto JY (1998) Role of ergosterol in growth inhibition of Saccharomyces cerevisiae by syringomycin E. FEMS Microbiol Lett 167:215–220PubMedCrossRefGoogle Scholar
  67. Wasser SP (2005) Reishi or Lingzhi (Ganoderma lucidum). Encycl Dietary Suppl.  https://doi.org/10.1081/E-EDS-120022119
  68. Wasser SP, Weis AL (1999) Medicinal properties of substances occurring in higher basidiomycetes mushrooms: current perspectives. Int J Med Mush 1:31–62CrossRefGoogle Scholar
  69. Weng Y, Lu J, Xiang L, Matsuura A, Zhang Y, Huang Q, Qi J (2011) Ganoderma sides C and D, two new anti-aging ergosterol from spores of the medicinal mushroom Ganoderma lucidum. Biosci Biotechnol Biochem 75(4):800–803PubMedCrossRefGoogle Scholar
  70. Wessel JGH (1994) Developmental regulation of fungal cell wall formation. Annu Rev Phytopathol 32:413–437CrossRefGoogle Scholar
  71. Windaus A (1928) Constitution of sterols and their connection with other substances occurring in nature. Noble LectureGoogle Scholar
  72. Wu QP, Xie YZ, Deng Z, Li XM, Yang W, Jiao CW, Fang L, Li SZ, Pan HH, Yee AJ, Lee DY, Li C, Zhang Z, Guo J, Yang BB (2012) Ergosterol peroxide isolated from Ganoderma lucidum abolishes microrna mir-378-mediated tumor cells on chemoresistance. PLoS One 7(8):e44579PubMedPubMedCentralCrossRefGoogle Scholar
  73. Yuan JP, Wang JH, Liu X (2007) Distribution of free and esterified ergosterol in the medicinal fungus Ganoderma lucidum. Appl Microbiol Biotechnol 77:159–165PubMedCrossRefGoogle Scholar
  74. Zaidman BZ, Yassin M, Mahajna J, Wasser SP (2005) Medicinal mushroom modulators of molecular targets as cancer therapeutics. Appl Microbiol Biotechnol 67:453–468PubMedCrossRefGoogle Scholar
  75. Zhao HB, Wang SZ, He QH, Yuan L, Chen AF, Lin ZB (2005) Ganoderma total sterol (GS) and GS1 protect rat cerebral cortical neurons from hypoxia/reoxygenation injury. Life Sci 76:1027–1037PubMedCrossRefGoogle Scholar
  76. Zhao L, Zhao G, Zhao Z, Chen P, Tong J, Hu X (2004) Selenium distribution in a se-enriched mushrooms species of the genus Ganoderma. J Agric Food Chem 52:3954–3959PubMedCrossRefGoogle Scholar
  77. Zheng L, Si J, Wong YS (2009) Ergosterol peroxide and 9,11-dehydroergosterol peroxide from ling zhi or reishi medicinal mushroom, Ganoderma lucidum (W. Curt.: Fr.) P. Karst. (Aphyllophoromycetideae) mycelia inhibit the growth of human breast adenocarcinoma MCF-7 cells. Int J Med Mush 11(3):248–257CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2018

Authors and Affiliations

  • Anna Goyal
    • 1
  • Anu Kalia
    • 2
  1. 1.Department of Microbiology, College of Basic Sciences and HumanitiesPunjab Agricultural UniversityLudhianaIndia
  2. 2.Electron Microscopy and Nanoscience Laboratory, Department of Soil Science, College of AgriculturePunjab Agricultural UniversityLudhianaIndia

Personalised recommendations